SOD3 and neoplasm: Re-expression of SOD3 in tumor-associated endothelial cells induces perivascular nitric oxide accumulation and reduces vessel leakage by up-regulating vascular endothelial cadherin (VE-cadherin) expression, thereby enhancing tumor response to chemotherapy [18].